Samuel Kintz - Feb 23, 2023 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role
President and CEO, Director
Signature
/s/ Ben Hohl, by power of attorney
Stock symbol
ELVN
Transactions as of
Feb 23, 2023
Transactions value $
$0
Form type
3
Date filed
2/27/2023, 08:24 PM
Next filing
Apr 6, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney